Clinical Trial

Effect of Ketosteril on Sarcopenia in Patients With Chronic Kidney Disease

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The investigators hypothesize that Ketosteril can improve sarcopenia in patients with renal disease without increasing the burden on the kidneys and causing deterioration of renal function. Therefore, this study intends to take patients with CKD stage 3-4 and sarcopenia as the research object, give Ketosteril intervention or not to patients on the base of low-protein diet, and clarify the clinical benefits of Ketosteril prescription for improving sarcopenia in patients with CKD.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-06-30 -> 2028-06-30 2026-07-29
minor Completion pushed: 2026-06-30 -> 2028-06-30 2026-07-29
Trial Details
NCT Number NCT06329622
Lead Sponsor Huashan Hospital
Conditions Chronic Kidney Disease, Sarcopenia
Enrollment 58 participants
Start Date 2024-05-01
Primary Completion 2028-06-30 (estimated)
Study Completion 2028-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-28